No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease

Neuroscience Letters

Volumn 290, Issue 2, 2000, Pages 154-156

  Shibata, Nobuto ^a   Ohnuma, Tohru ^a   Takahashi, Tadashi ^a   Ohtsuka, Emiko ^b   Ueki, Akira ^b   Nagao, Masatsugu ^c   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Jichi Medical University   (Japan)

^c Nagao Hospital   (Japan)

Author keywords

Alpha 2 macroglobulin; Genetic polymorphism; Sporadic Alzheimer's disease

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; PROTEINASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; HUMANS; JAPAN; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034714589     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01330-6     Document Type: Article

References (17)

1. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go Rodney C.P., Perry R., Watson B. Jr., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
2. Borth W. Alpha-2-macroglobulin, a multi-functional binding protein with targeting characteristics. FASEB J. 6:1992;3345-3353.
3. Dow D.J., Lindsey N., Cairns N.J., Brayne C., Robinson D., Huppert F.A., Paykel E.S., Xuereb J., Wilcock G., Whittaker J.L., Rubinsztein D.C. α-2 Macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat. Genet. 22:1999;16-17.
4. Hu C.J., Sung S.M., Liu H.C., Lee K.Y., Hsu W.C., Wong W.K., Lee C.C., Tsai C.H., Chang J.G. No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese. Neurology. 53:1999;642-643.
5. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., Sahasrabudhe S. Alpha-2-macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc. Natl Acad. Sci. USA. 95:1998;3275-3280.
6. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J.H., Tanzi R.E., Hymann B.T. Genetic association of an α2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease. Hum. Mol. Gen. 7:1998;1953-1956.
7. Matthijs G., Marynen P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucl. Acids Res. 19:1991;5102.
8. Pericak-Vance M.A., Bass M.L., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in Late-onset familial Alzheimer's disease. Neurobiol. Aging. 19:1998;39-42.
9. Poller W., Faber J.P., Klobeck G., Olek K. Cloning of the human alpha 2- macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. Hum. Genet. 88:1992;313-319.
10. Qiu W.Q., Borth W., Ye Z., Haass C., Teplow D., Selkoe D.J. Degradation of amyloid beta protein by a serine proteinase alpha-2-macroglobulin complex. J. Biol. Chem. 271:1996;8443-8451.
11. Rebeck W.G., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37:1995;211-217.
12. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., Song Y., Hill D.L., Abou-Donia S.M., Martin E.R., Vance J.J., Yu G., Orlacchio A., Pei Y., Nishimura M., Supala A., Roberge B., Saunders A.M., Roses A.D., Schmechel D., Crane-Gatherum A., Sorbi S., Bruni A., Small G.W., Conneally P.M., Haines J.L., Leuven F.V., George-Hyslop P.H.St., Farrer L.A., Pericak-Vance M.A. An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet. 22:1999;19-21.
13. Romas S.N., Mayeux R., Rabinowitz D., Tang M.X., Zadroga H.R., Lantigua R., Medrano M., Tycko B., Knowles J.A. The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. Neurosci. Lett. 279:2000;133-136.
14. Rudrasingham V., Vrieze F.W., Lambert J-C., Chakravently S., Kehoe P., Crook R., Amouyel P., Wu W., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Petersen R., Cottel D., Tunstall N., Holmans P., Lovestone S., Chartier-Harlin M-C., Goate A., Hardy J., Owen M.J., Williams J. α-2 Macroglobulin gene and Alzheimer's disease. Nat. Genet. 22:1999;17-19.
15. Shibata N., Ohnuma T., Takahashi T., Ohtsuka E., Ueki A., Arai H. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease. Neurosci. Lett. 271:1999;132-134.
16. Vrieze F.W., Rudrasingham V., Lambert J-C., Chakravently S., Kehoe P., Crook R., Amouyel P., Wu W., Holmans P., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Cottel D., Tunstall N., Lovestone S., Petersen R., Chartier-Harlin M-C., Goate A., Owen M.J., Williams J., Hardy J. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci. Lett. 262:1999;137-139.
17. Wenham P.R., Price W.H., Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.